Emergence of chronic myelogenous leukemia in a patient with primary thrombocythemia and absence of BCR/ABL rearrangement

Cancer Genetics and Cytogenetics

Volumn 167, Issue 1, 2006, Pages 74-77

  Cesar, Jesus M ^a   Cabello, Pablo ^a   Ferro, Teresa ^a   Navarro, J L ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANAGRELIDE; BCR ABL PROTEIN; HYDROXYUREA; IMATINIB;

ADULT; ARTICLE; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; DOSE RESPONSE; EVOLUTION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE EXPRESSION; GENE REARRANGEMENT; HUMAN; KARYOTYPE; LEUKOCYTE COUNT; METAPHASE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTHEMIA;

AGED; ANTINEOPLASTIC AGENTS; BLOOD PLATELETS; BONE MARROW CELLS; CELLS, CULTURED; CHROMOSOMES, HUMAN, PAIR 22; CHROMOSOMES, HUMAN, PAIR 9; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FIBRINOLYTIC AGENTS; FUSION PROTEINS, BCR-ABL; HUMANS; HYDROXYUREA; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; LEUKOCYTES; PIPERAZINES; PYRIMIDINES; QUINAZOLINES; THROMBOCYTHEMIA, HEMORRHAGIC; TIME FACTORS; TRANSLOCATION, GENETIC; TREATMENT OUTCOME;

EID: 33646203575     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2005.10.005     Document Type: Article

References (15)

1. Anger B., Janssen J.W., Schrezenmeier H., Hehlmann R., Heimpel H., and Bartram C.R. Clonal analysis of chronic myeloproliferative disorders using X-linked DNA polymorphisms. Leukemia 4 (1990) 258-261
2. Murphy S., Peterson P., Iland H., and Laszlo J. Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment. Semin Hematol 34 (1997) 29-39
3. Kralovics R., Passamonti F., Buser A.S., Soon-Siong T., Tiedt R., et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 352 (2005) 1779-1790
4. Stoll D.B., Peterson P., Exten R., Laszlo J., Pisciotta A.V., Ellis J.T., White P., Vaidya K., Bozdech M., and Murphy S. Clinical presentation and natural history of patients with essential Thrombocythemia and the Philadelphia chromosome. Am J Hematol 27 (1988) 77-83
5. Cervantes F., Colomer D., Vives-Corrons J.L., Rozman C., and Montserrat E. Chronic myeloid leukemia of thrombocytemic onset: a CML subtype with distinct hematological and molecular features. Leukemia 10 (1996) 1241-1243
6. Morris C.M., Fitzgerald P.H., Hollings P.E., Archer S.A., Rosman I., Beard M.E.J., Heaton D.C., and Newhook C.J. Essential Thrombocythemia and the Philadelphia chromosome. Br J Haematol 70 (1988) 13-19
7. Blickstein D., Aviram A., Luboshitz J., Prokocimer M., Stark P., Bairey O., Sulkes J., and Shaklai M. BCR-ABL transcripts in bone marrow aspirates of Philadelphia-negative essential Thrombocythemia patients: clinical presentation. Blood 90 (1997) 2768-2771
8. Wahlin A., and Golovleva I. Emergence of Philadelphia positive chronic myeloid leukaemia during treatment with hydroxyurea for Philadelphia negative essential thrombocythaemia. Eur J Haematol 70 (2003) 240-241
9. Cesar J.M., de Miguel D., García-Avello A., and Burgaleta C. Platelet dysfunction in primary thrombocythemia using the platelet function analyzer (PFA-100). Am J Clinic Pathol 123 (2005) 772-777
10. Rowlwy J.D. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243 (1973) 290-293
11. De Klein A., Guerts van Kessel A., Grosveld G., Bartram C.R., Bootsma D., Spurr N.K., Heisterkamp N., Groffen J., and Stephenson J.R. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia. Nature 300 (1982) 765-767
12. De Klein A. Oncogene activation by chromosomal rearrangement in chronic myelocytic leukaemia. Mutation Research 186 (1987) 161-172
13. Emilia G., Luppi M., Ferrari M.G., Temperani P., Marasca R., Giacobbi F., Bandieri E., Di Donato C., Carapezzi C., and Torelli G. Chronic myeloid leukaemia with thrombocythemic onset may be associated with different BCR/ABL variant transcripts. Cancer Genet Cytogenet 101 (1998) 75-77
14. Rice L., and Popat U. Every case of essential thrombocythemia should be tested for the Philadelphia chromosome. Am J Hematol 78 (2005) 71-73
15. Savage D.G., and Antman K.H. Imatinib mesylate: a new oral targeted therapy. N Engl J Med 346 (2002) 683-693